期刊文献+

284例泌尿系感染菌群分布及耐药性分析 被引量:12

暂未订购
导出
摘要 目的研究泌尿系感染菌群分布及药敏情况,为临床药物选择提供依据。方法回顾性分析2011年8月至2013年2月284例泌尿系感染患者中段尿细菌培养及药敏试验。结果 284株泌尿系感染病原菌菌群分布以革兰阴性杆菌居多,占63.4%,其中大肠埃希菌(46.8%)、鲍曼不动杆菌(4.2%)、肺炎克雷伯菌(3.5%)较为常见;革兰阳性球菌占29.6%,其中以屎肠球菌(17.3%)、粪肠球菌(7.4%)、凝固酶阴性葡萄球菌(4.2%)居多;真菌感染占7.0%,其中光滑念珠菌(3.2%)、克柔念珠菌(2.1%)、白色念珠菌(1.8%)均有检出。大肠埃希菌对氨苄西林、左氧氟沙星耐药现象较为严重,鲍曼不动杆菌对氨苄西林、头孢吡肟、左氧氟沙星耐药均高达60%以上;青霉素、红霉素对主要革兰阳性球菌高度耐药,万古霉素未发现耐药菌株。结论根据药敏试验合理用药有重要的临床意义。
出处 《检验医学与临床》 CAS 2014年第9期1223-1224,共2页 Laboratory Medicine and Clinic
  • 相关文献

参考文献9

二级参考文献49

共引文献46

同被引文献119

  • 1蒋利君,韦晓谋,梁陈方.革兰阴性杆菌产ESBLs与第三代头孢菌素用药频度分析[J].中华医院感染学杂志,2006,16(7):799-800. 被引量:36
  • 2郑姬,府伟灵,张晓兵.尿路感染常见病原菌的分布及耐药性分析[J].中华医院感染学杂志,2006,16(11):1294-1296. 被引量:30
  • 3ChenY,Ko W,Hsueh P.Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract in-fections[J].Expert Opinion on Pharmacotherapy,2013,14(5);587-596.
  • 4HsuehPR.Study for Monitoring Antimicrobial Resistance Trends(SMART)in the Asia-Pacific region,2002-2010[J].Int J Antimi-crob Agents,2012,40 Suppl:SI-S3.
  • 5LuPL,Liu YC,Toh HS,et al.Epidemiology and antimicrobial sus-ceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region:2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends(SMART)[J].Int J Antimicrob Agents,2012,40 Suppl:S37-S43.
  • 6HobanDJ,Lascols C,Nicolle LE,et al.Antimicrobial susceptibility of Enterobacteriaceae,including molecular characterization of ex-tended-spectrum beta-lactamase-producing species,in urinary tract isolates from hospitalized patients in North America and Eu-rope:results from the SMART study 2009-2010[J].Diagn Microbi-olInfect Dis,2012,74(1):62-67.
  • 7BouchillonS,Hoban DJ,Badal R,et al.Fluoroquinolone resistance among gram-negative urinary tract pathogens:global smart program results,2009-2010[J].Open Microbiol J,2012,6:74-78.
  • 8KanigaK,Flamm R,Tong SY,et al.Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-pro-ducing and ciprofloxacin-resistant Enterobacteriaceae:analysis of six phase 3 clinical studies[J].Antimicrob Agents Chemother,2010,54(5):2119-2124.
  • 9AlexanderBT,Marschall J,Tibbetts RJ,et al.Treatment and clini-cal outcomes of urinary tract infections caused by KPC-producing Enterobacteriaceae in a retrospective cohort[J].Clin Ther,2012,34(6):1314-1323.
  • 10Sievert DM,Ricks P,Edwards JR,et al.Antimicrobial-resistant pathogens associated with healthcare-associated infections:sum-mary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention,2009-2010[J].In-fect Control Hosp Epidemiol,2013,34(1):1-14.

引证文献12

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部